- Home
- TNGX vs IRBT Comparison
TNGX vs IRBT Comparison
Compare TNGX & IRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- IRBT
- Stock Information
- Founded
- TNGX 2014
- IRBT 1990
- Country
- TNGX United States
- IRBT United States
- Employees
- TNGX N/A
- IRBT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- IRBT Consumer Electronics/Appliances
- Sector
- TNGX Health Care
- IRBT Consumer Discretionary
- Exchange
- TNGX Nasdaq
- IRBT Nasdaq
- Market Cap
- TNGX 248.2M
- IRBT 257.3M
- IPO Year
- TNGX N/A
- IRBT N/A
- Fundamental
- Price
- TNGX $2.49
- IRBT $3.06
- Analyst Decision
- TNGX Strong Buy
- IRBT Hold
- Analyst Count
- TNGX 6
- IRBT 1
- Target Price
- TNGX $12.20
- IRBT N/A
- AVG Volume (30 Days)
- TNGX 3.5M
- IRBT 3.0M
- Earning Date
- TNGX 05-12-2025
- IRBT 05-06-2025
- Dividend Yield
- TNGX N/A
- IRBT N/A
- EPS Growth
- TNGX N/A
- IRBT N/A
- EPS
- TNGX N/A
- IRBT N/A
- Revenue
- TNGX $40,990,000.00
- IRBT $633,404,000.00
- Revenue This Year
- TNGX N/A
- IRBT $3.23
- Revenue Next Year
- TNGX N/A
- IRBT $28.90
- P/E Ratio
- TNGX N/A
- IRBT N/A
- Revenue Growth
- TNGX 10.09
- IRBT N/A
- 52 Week Low
- TNGX $1.03
- IRBT $1.76
- 52 Week High
- TNGX $12.02
- IRBT $13.45
- Technical
- Relative Strength Index (RSI)
- TNGX 62.72
- IRBT 50.39
- Support Level
- TNGX $1.93
- IRBT $2.49
- Resistance Level
- TNGX $2.67
- IRBT $4.22
- Average True Range (ATR)
- TNGX 0.39
- IRBT 0.40
- MACD
- TNGX 0.07
- IRBT 0.05
- Stochastic Oscillator
- TNGX 55.38
- IRBT 23.15
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About IRBT iRobot Corporation
iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.